Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer

Clinical trial NCT04416490 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04416490
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Stage II Colon Cancer Stage III Colon Cancer

Start date: 2020-03-25
Primary completion: 2027-02-01
Enrollment: 2013

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.